Free Trial
NASDAQ:LFVN

LifeVantage (LFVN) Stock Price, News & Analysis

LifeVantage logo
$11.91 +0.20 (+1.71%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$11.91 0.00 (0.00%)
As of 05/2/2025 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LifeVantage Stock (NASDAQ:LFVN)

Key Stats

Today's Range
$11.65
$12.06
50-Day Range
$11.71
$17.17
52-Week Range
$5.22
$27.38
Volume
204,913 shs
Average Volume
131,523 shs
Market Capitalization
$149.48 million
P/E Ratio
21.27
Dividend Yield
1.34%
Price Target
$30.50
Consensus Rating
Buy

Company Overview

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LifeVantage Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

LFVN MarketRank™: 

LifeVantage scored higher than 84% of companies evaluated by MarketBeat, and ranked 263rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeVantage has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    LifeVantage has received no research coverage in the past 90 days.

  • Read more about LifeVantage's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeVantage is 21.27, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.98.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeVantage is 21.27, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.71.

  • Price to Book Value per Share Ratio

    LifeVantage has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeVantage's valuation and earnings.
  • Percentage of Shares Shorted

    17.26% of the float of LifeVantage has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeVantage has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in LifeVantage has recently increased by 14.47%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LifeVantage pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    LifeVantage does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of LifeVantage is 28.57%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about LifeVantage's dividend.
  • Percentage of Shares Shorted

    17.26% of the float of LifeVantage has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeVantage has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in LifeVantage has recently increased by 14.47%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    LifeVantage has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for LifeVantage this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeVantage insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $161,200.00 in company stock.

  • Percentage Held by Insiders

    20.65% of the stock of LifeVantage is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.32% of the stock of LifeVantage is held by institutions.

  • Read more about LifeVantage's insider trading history.
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Stock News Headlines

LifeVantage (LFVN) Receives a Buy from Lake Street
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
LifeVantage (LFVN) Gets a Buy from Lake Street
See More Headlines

LFVN Stock Analysis - Frequently Asked Questions

LifeVantage's stock was trading at $17.53 at the start of the year. Since then, LFVN stock has decreased by 32.1% and is now trading at $11.91.
View the best growth stocks for 2025 here
.

LifeVantage Co. (NASDAQ:LFVN) posted its quarterly earnings data on Wednesday, February, 5th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.08. LifeVantage had a trailing twelve-month return on equity of 34.29% and a net margin of 3.46%.
Read the conference call transcript
.

Top institutional shareholders of LifeVantage include Envestnet Asset Management Inc. (1.10%), Bank of New York Mellon Corp (0.56%), Ritholtz Wealth Management (0.48%) and Calamos Advisors LLC (0.27%). Insiders that own company stock include Judd Dayton, Darwin Lewis, Raymond B Greer, Garry Paul Mauro and Michael A Beindorff.
View institutional ownership trends
.

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeVantage investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
2/05/2025
Record date for 3/17 Dividend
3/03/2025
Ex-Dividend for 3/17 Dividend
3/03/2025
Dividend Payable
3/17/2025
Today
5/03/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LFVN
Employees
260
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.50
High Stock Price Target
$35.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+156.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
21.27
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.94 million
Pretax Margin
4.86%

Debt

Sales & Book Value

Annual Sales
$212.15 million
Cash Flow
$0.63 per share
Price / Cash Flow
19.03
Book Value
$2.38 per share
Price / Book
5.00

Miscellaneous

Free Float
9,959,000
Market Cap
$149.48 million
Optionable
Optionable
Beta
0.41

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:LFVN) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners